A Pilot Study of Changes in Circulating Tumor-Specific DNA in Patients with Non-Metastatic Non-Small Cell Lung Cancer

What we are studying

The purpose of this research study is to determining the feasibility of using a blood test to measure circulating tumor DNA (ctDNA). Investigationers believe that ctDNA may identify patients who can be considered for additional therapy.

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • N/A

What is involved

  • Blood draws
  • Quality of life questionnaires


Parking Compensation

Contact Information

Study Coordinator
Sharon Averill, RN
[email protected]

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.